New Century Logistics (BVI) Limited Regains Nasdaq Compliance After 1‑for‑8 Reverse Split

NCEW
March 09, 2026

New Century Logistics (BVI) Limited regained compliance with Nasdaq’s minimum bid price rule after the exchange confirmed that the company’s closing bid price had remained at or above $1.00 for 12 consecutive business days from November 14 to December 2 2025. The company had been notified on August 12 2025 that its bid price had fallen below the $1.00 threshold for 30 consecutive business days, prompting a compliance action.

The company’s 1‑for‑8 reverse stock split, effective November 14 2025, was the key step that lifted the per‑share price above the minimum requirement. By consolidating eight shares into one, the split increased the bid price, allowing the company to meet Nasdaq’s rule and avoid delisting proceedings.

While the regulatory outcome is positive, it does not resolve underlying financial challenges. New Century Logistics has reported declining earnings, with an average annual drop of 115.4%, and revenue has fallen at an average rate of 10.3% per year, indicating significant operational headwinds beyond the bid price issue.

The event underscores the importance of maintaining bid price compliance for micro‑cap companies. Failure to meet the $1.00 threshold can trigger delisting, severely limiting liquidity and access to capital markets. By regaining compliance, the company preserves its listing status and mitigates a key regulatory risk that could have eroded investor confidence.

The company has not announced any new strategic initiatives or management changes as a result of the compliance restoration. Investors will likely focus on the company’s ability to reverse its declining earnings trajectory and stabilize revenue growth in the coming periods.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.